A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma. (14th February 2020) - Lee, Hun J.; Schmelz, Jacob L.; Cramer, Fred; Romaguera, Jorge E.; Badillo, Maria; Wang, Michael